The Discovery of the CCR5 Receptor Antagonist, UK-427,857, A New Agent for the Treatment of HIV Infection and AIDS
- 1 January 2005
- book chapter
- Published by Elsevier in Progress in Medicinal Chemistry
- Vol. 43, 239-271
- https://doi.org/10.1016/s0079-6468(05)43007-6
Abstract
No abstract availableThis publication has 68 references indexed in Scilit:
- HIV Type 1 Isolates from 200 Untreated Individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large Predominance of CRF01_AE and Presence of Major Resistance Mutations to Antiretroviral DrugsAIDS Research and Human Retroviruses, 2003
- Toxicity of antiretroviral therapy and implications for drug developmentNature Reviews Drug Discovery, 2003
- Twenty years of therapy for HIV-1 infectionNature Medicine, 2003
- HIV and AIDS: 20 years of scienceNature Medicine, 2003
- Antiretroviral-Drug Resistance among Patients Recently Infected with HIVNew England Journal of Medicine, 2002
- Adherence to HAART among patients with HIV: Breakthroughs and barriersAIDS Care, 2002
- Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophyAIDS, 2001
- Resistance to antiretroviral drugs in patients with primary HIV-1 infectionInternational Journal of Antimicrobial Agents, 2000
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983
- Isolation and Transmission of Human Retrovirus (Human T-Cell Leukemia Virus)Science, 1983